Rick Simpson Oil (RSO) in Lawrence County, Alabama: The Complete Guide by OilWell Cannabis

Living in Lawrence County means we understand resilience. From the rolling fields of Moulton to the quiet neighborhoods of Town Creek, from the hardworking families in Courtland to the veterans who’ve served our country and now call this place home — we know what it means to push through when things get tough. We also know what it means when the system doesn’t have all the answers. When the doctor says, “We’ve done all we can,” or when the pharmacy line stretches your patience thin, or when you’re watching someone you love suffer and feeling helpless — that’s when people in Lawrence County start looking for real alternatives.

That’s exactly why we at OilWell Cannabis wrote this guide. And it’s why we need to talk about Rick Simpson Oil — not with hype, not with miracle-cure promises, but with the honest, science-backed truth that people in Lawrence County deserve.

Who Is Rick Simpson, and What Is Traditional RSO?

If you’ve spent any late nights researching cannabis oil online, you’ve probably seen the name Rick Simpson. Born in 1949 in Amherst, Nova Scotia, Canada, Rick Simpson wasn’t a doctor, scientist, or medical professional. He was a power engineer and maintenance worker — a blue-collar tradesman whose life changed when conventional medicine failed him.

In 1997, while working at a hospital in Moncton, Simpson fell from a scaffolding and suffered a serious head injury. The aftermath included persistent tinnitus, dizziness, and post-concussion symptoms that his doctors couldn’t resolve. The medications either didn’t help or made things worse. When he asked his physician about cannabis as an option, the request was refused. Sound familiar? Many folks here in Lawrence County have walked into a doctor’s office in Huntsville or Decatur and been told the same thing: “We don’t do that here.”

Simpson’s interest in concentrated cannabis oil deepened after he learned about a 1974 NIH-funded study at the Medical College of Virginia, where THC was reported to slow or shrink tumors in mice. That study — originally intended to demonstrate harm — became a foundational reference point for Simpson, even though its findings were never replicated in controlled human cancer trials.

The pivotal moment came in 2003. Simpson reported that three bumps on his arm were diagnosed as basal cell carcinoma. Rather than pursuing conventional treatment, he applied concentrated cannabis oil directly to the lesions. According to his account, the bumps disappeared within four days. No independent medical verification was ever published. No biopsy confirmation exists. But this personal testimony became the origin story of Rick Simpson Oil and the catalyst for a global movement.

Important context: Simpson’s account is his personal testimony — not medical evidence. The absence of clinical documentation means these events cannot be evaluated as scientific proof. However, they are historically significant as the catalyst that launched a worldwide conversation about cannabis oil.

The Crusade: How RSO Became a Movement

After his 2003 experience, Simpson committed himself to producing and distributing concentrated cannabis oil from his property in Maccan, Nova Scotia. He gave it away for free — yes, completely free — to cancer patients and others in his community. He claimed to help people with cancer, chronic pain, diabetes, infections, glaucoma, arthritis, depression, insomnia, and more.

His story reached a global audience through the 2005 documentary Run From The Cure, which documented his claims and became one of the most widely shared cannabis advocacy films of its era. For many people worldwide — and likely some here in Lawrence County — that documentary was their first introduction to the concept of concentrated cannabis oil as medicine.

But Simpson’s advocacy brought him into direct conflict with Canadian law. The Royal Canadian Mounted Police raided his property in 2005 and 2009. He was charged with cultivation, possession, and trafficking. Facing continued legal pressure, he eventually left Canada and relocated to Europe, where he continued his advocacy from abroad.

In 2012, he published Phoenix Tears: The Rick Simpson Story, detailing his experience and oil-making process. He maintained that cannabis oil could cure cancer and that pharmaceutical companies, government agencies, and medical institutions were actively suppressing this knowledge.

What he got right: Simpson drew attention to cannabinoids as a serious biomedical research area when the world was ignoring it. He helped create the conditions for the legal cannabis industry. The term “RSO” remains the most recognized name for full-spectrum cannabis extract.

What he overstated: Cancer cure claims have never been proven in human trials. Encouraging patients to use RSO instead of proven cancer therapies carries genuine harm potential. Delayed or foregone treatment is a documented concern in alternative medicine.

The Traditional RSO Protocol: Simpson’s 60-Gram, 90-Day Regimen

Simpson’s core treatment recommendation was a structured oral protocol: 60 grams of concentrated cannabis oil over roughly 90 days. Here’s the breakdown as he described it:

Week 1: Begin with a dose the size of half a grain of rice — about 10-15 mg of oil — three times daily. Total daily intake: 30-45 mg.

Weeks 2-5: Double the dose every four days to build tolerance gradually. By week five, reach approximately 1 gram per day, divided into three doses.

Weeks 5-12: Maintain 1 gram per day (about 333 mg per dose) until all 60 grams are consumed.

Administration methods:

• Oral: Place under tongue or swallow (primary method for internal cancers)
• Topical: Apply directly to lesions for skin cancers
• Inhalation: Not recommended as primary treatment, though acknowledged for symptom relief

Tolerance and psychoactive effects: Simpson maintained patients develop tolerance within 3-4 weeks. He recommended nighttime dosing initially and warned against driving.

Post-protocol maintenance: After completing the 60-gram course, Simpson recommended 1-2 grams per month indefinitely.

Important context for evaluating this protocol:

• No controlled trial validation exists
• The protocol assumes crude, unstandardized material with unknown potency
• Peak dosing delivers approximately 600-900 mg of delta-9 THC daily — far exceeding anything studied clinically
• Real risks at these doses include severe intoxication, anxiety, panic, tachycardia, hypotension, and cannabis use disorder
• Patients with active cancer are medically complex; using unregulated oil as primary treatment introduces serious harm potential

What Traditional RSO Actually Was

Traditional RSO was defined by Simpson’s method, not lab specifications:

Source material: Single high-THC indica strains — no standardization.

Extraction solvent: Naphtha (petroleum-based lighter fluid) or 99% isopropyl alcohol — neither food-grade.

Process: Plant material soaked in solvent, filtered, then evaporated in a rice cooker. High heat destroyed terpenes and fully decarboxylated THCa into THC.

Appearance: Nearly black, thick, tar-like oil with strong cannabis odor and possible solvent-residual smell.

Cannabinoid profile: Fully decarboxylated, THC-dominant (60-90% estimated), minor cannabinoids at natural ratios — uncontrolled, unmeasured, never lab-verified.

Terpene content: Minimal to none — destroyed by solvent and heat.

Standardization and testing: None. Every batch was different.

Residual solvent risk: Naphtha may contain benzene, toluene, and other carcinogens. Incomplete purging is difficult to verify without lab testing.

Why OilWell’s Formulas Diverge From Traditional RSO

We at OilWell Cannabis respect the RSO origin story — but we built something deliberately different, solving problems that limited Rick Simpson’s original vision:

1. Multi-cannabinoid approach: Traditional RSO used whatever single strain was available. Our formula includes seven defined cannabinoids at specific ratios because the entourage-effect literature suggests potential benefit from cannabinoid diversity [20][29].

2. Terpene preservation and addition: Traditional RSO had no terpenes. We include live terpenes at 5% with a specific seven-terpene profile because terpene bioactivity is plausible and supported at the preclinical level [20][21][23][24][25][26][27][28][29].

3. THCa as a separate ingredient: Traditional RSO fully decarboxylated everything. We preserve THCa at 1,500 mg because the THCa literature suggests potentially relevant non-psychoactive bioactivity that is lost when THCa converts to THC [12].

4. Reduced delta-9 THC dominance: Traditional RSO was 60-90% delta-9 THC. Our formula uses only 90 mg delta-9 THC while incorporating 6,000 mg delta-8 THC and distributing remaining cannabinoids across CBD (4,500 mg), CBG (3,000 mg), CBN (750 mg), and CBC (750 mg).

5. Product format innovation: Simpson envisioned only a syringe format. We offer both a 30 mL sublingual oil and a 1-gram vape cartridge, each with format-specific formulations acknowledging different pharmacokinetic profiles [14].

The OilWell Story: From McAllen to Houston to Lawrence County

OilWell Cannabis was founded by Colin Valencia in Houston, Texas. But Colin’s story begins far from Houston — in McAllen, Texas, right across the river from Reynosa, Tamaulipas, Mexico. The McAllen-Reynosa Borderplex is one of the most economically challenged and dangerous regions along the U.S.-Mexico border. Growing up there meant learning to hustle early, taking on risky work transporting items across the border. A lot of his best friends have been killed or are in prison because of those associated dangers. By sixteen, he had to leave home for good.

Despite the dangers, Colin did not fall into the darkest paths. He focused on cannabis, seeing it as a safer alternative. He grew up in the traditional cannabis world long before legalization, learning the plant intimately while operating in the shadows. Over time, he transitioned from those early, risky ventures to creating a legal, legitimate business.

Colin later became a formally trained software engineer and did custom development work for Baylor College of Medicine — one of the most prestigious medical institutions in the Texas Medical Center. That combination of deep cannabis plant knowledge plus medical-grade technical precision defines OilWell’s approach.

But the company truly began with a dog named Bentley. Bentley was more than a pet — he was family. When veterinarians delivered the verdict no pet owner wants to hear (euthanasia was the only humane option; Bentley was paralyzed in his back legs, pain medications would destroy his organs), Colin refused to give up.

A rescue worker named Jessica asked the question that changed everything: “You’ve moved how many tons of weed and you’ve never heard of CBD?” Colin had cannabis experience — but it was recreational. He’d never explored therapeutic applications.

Determined to save Bentley, Colin learned to create CBD golden paste. It was not a cure, but it was a lifeline. And that hope delivered something veterinary medicine said was impossible: Bentley got up, walked over to Colin, and brought him his ball to play. From paralyzed and facing euthanasia to fetching his ball. This was not placebo effect — dogs do not respond to placebo. This was cannabinoid medicine doing what pharmaceuticals could not.

Bentley lived another ten years, passing naturally at age twenty. During those years, Colin developed specialized cannabis formulas for every age-related condition Bentley faced. Neurodegeneration led him to understand CBG’s neuroprotective properties and THCa’s PPARγ agonism for brain cell protection. Dementia led him to CBC’s role in neurogenesis. Glaucoma led him to THC’s CB1 agonism for intraocular pressure. Crippling arthritis led him to develop multi-pathway anti-inflammatory approaches using CBD, CBG, THCa, and beta-caryophyllene working through different receptor systems simultaneously.

Single cannabinoids were not enough. Bentley’s evolving conditions required multi-cannabinoid synergy. This is why OilWell’s RSO has seven cannabinoids instead of one or two — it wasn’t a marketing decision; it was born from necessity. Pharmaceutical precision mattered; Bentley’s life depended on formula accuracy.

Colin also knows pharmaceutical dependence personally. He struggled with PTSD and benzodiazepine addiction. When he broke free from Xanax, he did it cold turkey using the cannabinoid knowledge he developed keeping Bentley alive. The Peace Gummies formula was created during midnight experiments while fighting through benzo withdrawal. Colin personally uses the vape form to manage his insomnia and severe PTSD. This is not theoretical knowledge — he lived what RSO patients live.

Over time, Colin developed formulas that doctors use for Crohn’s disease, IBS, ulcerative colitis, PTSD, benzo addiction, and insomnia. His focus has always been making cannabis accessible and effective for everyone, including vegans, diabetics, and those with specific health needs.

ABC13 KTRK Houston — the city’s number-one news source — featured Colin in seven comprehensive news segments from 2019 to 2023, repeatedly selecting him as the primary cannabis industry expert for coverage spanning law, medicine, community health, and politics. No other Houston cannabis operator matches that frequency or breadth.

Colin’s quote from his first ABC13 feature in September 2019 captures our philosophy: “I’m not trying to sell people snake oil. I’m not trying to sell people hope. But there’s enough research out there that people just need to know and try and have the best possible version to base their opinions off of to give it a fair shot as to whether it’s right or wrong for them.”

Today, OilWell Cannabis operates from Montrose, Houston (810 Richmond Avenue, Houston, TX 77006). We’ve been operating since 2019, generate approximately one million dollars in annual revenue, maintain a near-5.0 Google rating, and are Texas DSHS licensed. All artwork, formulations, and packaging are created in-house in Houston. We bring Houston grit, McAllen roots, and a builder’s mindset to everything we do, but the posture stays simple: make products with intent, answer directly, and never pretend cannabis is right for everyone.

The OilWell RSO Philosophy: Four Core Principles

1. Accessibility Over Gatekeeping

No medical card is required. Anyone age twenty-one or older can purchase. We ship nationwide and internationally to customers who verify local legality. Rick Simpson believed medicine should be accessible to everyone; we built a product and distribution model that makes that accessible legally.

For residents of Lawrence County, where the nearest medical cannabis dispensary might be hours away in Birmingham or Huntsville, this accessibility is crucial. You don’t need to drive two hours, pay for a doctor’s visit, and jump through Alabama’s restrictive medical program hoops. If you’re dealing with chronic pain from years of farm work, or chemotherapy side effects, or PTSD from military service, you can access our products directly.

2. Patient-Controlled Potency

THCa is sold in its acidic, non-psychoactive form. You decide whether to use it raw for non-psychoactive benefits or decarboxylate it into delta-9 THC for full psychoactive potency. Rick Simpson believed patients should control their own medicine; we engineered a product that puts that control in your hands through chemistry.

For Lawrence County residents who need to work, drive tractors, operate machinery, or parent during the day, this is freedom. You can use the raw form (Option 1) for daytime functional relief with zero impairment. At night, when you need stronger relief for pain or sleep, you can activate it (Option 2 or 3).

3. Open-Source Formulas

We publish our complete formulas publicly — every cannabinoid, every milligram amount, every percentage — so anyone who cannot afford the product can source ingredients and make their own version. Rick Simpson gave his oil away for free and taught people how to make it; we adapted that ethos for the modern marketplace by selling a professionally manufactured product and publishing the recipe.

In Lawrence County, where median household income is below the national average and many families are budget-conscious, this matters. If $129.99 is out of reach right now, you still have options. The formula is public. Quality hemp-derived cannabinoid distillates are increasingly available online. You can make your own RSO following our exact specifications.

4. Evidence-Informed, Not Evidence-Overstating

The GENERAL KNOWLEDGE section of this document represents our commitment to honest education about what science actually says. Rick Simpson operated without access to peer-reviewed literature or clinical trial data; we have that access and use it to distinguish between what is well-supported, what is emerging, and what is overstated.

For our neighbors in Lawrence County who’ve seen too many miracle-cure scams and too many broken promises, this honesty is everything. We won’t tell you RSO cures cancer. We will tell you what the preclinical literature shows and what it doesn’t. We will show you the NIH positions. We will give you the actual research citations so you can verify everything yourself.

Farm Bill Compliance and the THCa Legal Framework

The 2018 Farm Bill legalized hemp-derived products containing less than 0.3% delta-9 THC at the federal level. This is the foundation of our product design.

Our RSO Sublingual Oil contains only 90 mg of delta-9 THC in the entire 30 mL bottle — 3 mg per mL — well under the 0.3% threshold. All cannabinoids are hemp-derived. The product is legal under federal law and in all 50 states.

THCa is the acidic, non-psychoactive precursor to delta-9 THC. It is not itself delta-9 THC, so it’s Farm Bill compliant at the point of sale. The practical significance is substantial: you can decarboxylate THCa into delta-9 THC at home by heating the oil at 260°F (125°C) for 45-60 minutes.

The conversion chemistry: 1,500 mg of THCa converts to approximately 1,315 mg of delta-9 THC (the conversion ratio is ~0.877:1, accounting for the loss of a CO₂ molecule). Combined with the existing 90 mg delta-9 THC, this yields approximately 1,405 mg total delta-9 THC — giving the product psychoactive potency comparable to traditional illegal RSO, entirely at your discretion after purchase.

This means the same product can function as:

• Non-psychoactive anti-inflammatory (used raw) for daytime use
• Full-potency psychoactive cannabinoid medicine (after decarboxylation) for nighttime relief

Important legal notice for Lawrence County residents: THCa converts to delta-9 THC when heated. You are responsible for understanding and complying with Alabama state law. Our products ship with full documentation, Certificates of Analysis, and receipts. International customers accept all customs and legal risk. While hemp-derived products are legal at the federal level and in Alabama, always verify current local regulations.

Open-Source Formulas: Why We Publish Everything

We publish our complete RSO formulas publicly — every cannabinoid, every milligram amount, every percentage — so that anyone who cannot afford our products can source ingredients and make their own version. This is a direct echo of Rick Simpson’s original ethos. He gave his oil away for free and taught people how to make it. He never patented his method. We adapted that ethos for the modern marketplace: we sell a professionally manufactured, lab-tested, standardized product for those who want it, and we publish the complete recipe for those who want to make it themselves.

In Lawrence County, where the cost of living has risen but wages haven’t kept pace, this matters. If $129.99 for a bottle of RSO or $49.99 for a vape cartridge stretches your budget too far, you still have access to the knowledge. The formulas are published later in this document. Quality hemp-derived cannabinoid distillates are available from reputable suppliers. You can follow our exact specifications and create your own therapeutic oil.

The Original Open-Source Formula: Bentley’s CBD Golden Paste

This ethos didn’t start with our RSO — it started with Bentley. On our About Us page, we published the actual CBD golden paste recipe that saved Bentley’s life, so any pet owner facing a similar crisis could make it themselves:

Ingredients:

• 1/2 cup organic turmeric powder
• 1 cup water
• 1/3 cup unrefined organic coconut oil
• 1-2 teaspoons freshly ground black pepper (critical for absorption)
• CBD oil (dosage depends on pet size; consult a veterinarian)

Instructions:

1. Mix turmeric and water in a saucepan over low heat, stirring continuously for 7-10 minutes until it forms a thick paste. Add water if too thick.
2. Add coconut oil and black pepper; stir until thoroughly mixed.
3. Allow to cool, then transfer to a jar. Refrigerate for up to two weeks.
4. Add CBD oil to the paste before serving, adjusting dosage based on weight and health needs. Start low and increase gradually.
5. Mix a small amount with pet’s food once or twice daily. Always consult a veterinarian first.

This pattern is consistent: we give away the formula that saves lives. We did it for Bentley before we did it for people. The open-source ethos is not a marketing strategy — it’s our foundational behavior.

The Decarboxylation Choice: Patient-Controlled Potency

Traditional RSO was always fully decarboxylated, always psychoactive. We give you three distinct usage options from one product:

Option 1 — Raw, No Heat: All 1,500 mg stays as THCa — completely non-psychoactive. The THCa evidence profile shows potential anti-inflammatory activity via COX-2 inhibition and neuroprotective potential via PPARγ agonism [12]. This is perfect for Lawrence County residents who need daytime relief without impairment — whether you’re heading to work at the plant, driving to Decatur for errands, or operating farm equipment. Zero psychoactive effects.

Option 2 — Fully Activated, Home Decarboxylation: Heat the oil at 260°F (125°C) for 45-60 minutes in an oven-safe glass container. This converts 1,500 mg THCa into approximately 1,315 mg delta-9 THC. Combined with the existing 90 mg delta-9 THC, you get ~1,405 mg total delta-9 THC — achieving psychoactive potency comparable to traditional illegal RSO, 100% legally because you control the activation. You can decarboxylate the entire bottle or transfer a controlled portion to a second container, preserving the remainder raw.

Option 3 — Vape, Auto-Decarboxylation: Our RSO Vape Cartridge vaporizes at 400-450°F, instantly converting THCa to delta-9 THC with each puff. This is the fastest-onset RSO delivery method available — ideal for breakthrough pain, panic attacks, or acute nausea.

This design puts the potency decision entirely in your hands — aligning with Rick Simpson’s principle that patients should control their own medicine, but implementing it through actual product chemistry.

Solvent-Free Production: Safety You Can Verify

Traditional RSO used toxic solvents like naphtha. Our RSO is a formulated blend of individual cannabinoid distillates and isolates combined in a controlled production environment. No naphtha. No isopropyl alcohol. No butane. No extraction solvents in the finished product.

We use organic MCT oil as the carrier base — a food-grade lipid that facilitates sublingual absorption and provides a neutral taste. No tar-like consistency. No solvent-residual odor.

Every batch undergoes third-party lab testing covering:

• Cannabinoid potency
• Terpene profile
• Pesticides (400+ compound screening)
• Heavy metals (arsenic, cadmium, lead, mercury)
• Residual solvents (FDA Class 3 limits)
• Microbial contaminants

Certificates of Analysis are available on our website or by request. For Lawrence County residents who’ve heard horror stories about contaminated products, this transparency matters. You can verify exactly what you’re putting in your body.

Our Product Portfolio: Beyond RSO

While RSO is our flagship, we produce other cannabinoid products born from the same formulation knowledge:

Asshole Peach — Our most popular product. These peach gummy rings deliver 268 mg total cannabinoids per piece with a unique blend of delta-9, delta-8, delta-10, THCo, CBD, and CBG. Particularly favored by veterans for PTSD and pain relief.

Peace Gummies — Developed directly from Colin’s own experience with PTSD and benzodiazepine addiction. These helped him quit Xanax cold turkey. Available in gummy and vape forms for quick relief. Each peach contains 320 mg total cannabinoids including 30 mg CBN for sleep and recovery.

Custom Creations — We design tailored products on request for specific cannabinoid ratios, delivery formats, or health circumstances. This includes formulations for vegans, diabetics, and those with specific dietary needs.

RSO Product Formats: Which Is Right for You?

We offer our RSO formula in two delivery formats, each designed for different needs:

RSO Sublingual Oil — $129.99

• 30 mL bottle (1 fl oz)
• 16,590 mg total cannabinoids (553 mg/mL)
• Seven cannabinoids: CBD 4,500 mg, CBG 3,000 mg, delta-8 THC 6,000 mg, THCa 1,500 mg, delta-9 THC 90 mg, CBN 750 mg, CBC 750 mg
• 5% live terpenes: limonene, myrcene, caryophyllene, pinene, linalool, humulene, terpinolene
• Organic MCT oil base
• Graduated dropper: precise dosing in 0.1 mL increments
• Onset: 15-45 minutes (sublingual)
• Peak effects: 1-2 hours
• Duration: 4-6 hours
• Bioavailability: 13-19%
• Approximately 40-60 doses per bottle

RSO Vape Cartridge — $49.99

• 1-gram cartridge
• 900 mg+ total cannabinoids
• Same six-cannabinoid ratio (no separate delta-9 listing — auto-decarbs when vaped)
• 5%+ live terpenes
• 510-thread compatibility (works with standard vape batteries available locally)
• Onset: 1-2 minutes (fastest delivery)
• Peak effects: 10-15 minutes
• Duration: 2-4 hours
• Bioavailability: 10-35%

When to Use Each Format in Lawrence County

Use Case	Recommended Format	Why It Works
Fast relief (acute pain, panic attack, breakthrough nausea)	Vape	1-2 minute onset — crucial when you’re in crisis
Sustained relief (chronic pain, all-day management)	Sublingual	4-6 hour duration keeps you stable through a workday
Maximum bioavailability	Sublingual	13-19% absorption means more medicine reaching your system
Portability/discretion	Vape	Compact, no measuring — fits in your pocket at the Moulton courthouse or Decatur mall
Precise dosing control	Sublingual	0.1 mL increments let you dial in exactly what you need
Daytime non-psychoactive use (working, driving, parenting)	Sublingual raw	THCa stays inactive — zero impairment for operating equipment or driving Highway 157
Nighttime psychoactive use (severe pain, insomnia)	Sublingual decarbed or Vape	Activated THCa + delta-8 THC for maximum therapeutic effect

How We Stack Up: RSO Comparisons for Lawrence County

OilWell RSO vs. Alabama’s Medical Cannabis Program

• Access: Alabama’s program requires a medical card with qualifying conditions (cancer, PTSD, terminal illness, etc.). OilWell requires only age 21+ verification.
• Convenience: Alabama has few dispensaries — likely none in Lawrence County. We ship directly to your door in Moulton, Courtland, or anywhere in Lawrence County.
• Potency control: Alabama dispensary products are fully activated THC. Our THCa preservation lets you choose non-psychoactive or full-potency.

OilWell RSO vs. Hemp CBD RSO (e.g., Lazarus Naturals)

Dimension	Lazarus Naturals RSO (10 mL, 1,000 mg)	OilWell RSO (30 mL, 16,590 mg)
Total cannabinoids	1,000 mg	16,590 mg
CBD content	~950 mg	4,500 mg
CBG content	15.5 mg	3,000 mg
CBN content	0.7 mg	750 mg
Delta-8 THC	0 mg	6,000 mg
THCa (convertible)	Minimal	1,500 mg (→1,315 mg delta-9)
Psychoactive option	No	Yes
Price	$40-50	$129.99

For Lawrence County residents dealing with serious conditions, the 16x higher cannabinoid content and multi-cannabinoid synergy make OilWell the clinical-strength choice.

Condition-Specific Usage Context for Lawrence County Residents

Important disclaimer: These contexts are informed by research cited in our GENERAL KNOWLEDGE section. They are not medical prescriptions, not FDA-approved treatments, and not substitutes for professional medical care. Always consult a qualified healthcare provider before using cannabinoid products, especially if you have a medical condition, take medications, are pregnant or nursing, or have health concerns. Do not operate vehicles or machinery while under the influence of psychoactive cannabinoids.

Chemotherapy-Related Nausea and Appetite Support

Typical Lawrence County scenario: You’re driving to Huntsville Hospital or Decatur Morgan for chemo treatments. The drive is an hour each way, and the nausea hits hard.

Our recommendation:

• Pre-chemo: 0.5-1.0 mL sublingual approximately 1 hour before treatment
• Acute breakthrough nausea: 2-3 vape puffs for immediate relief (1-2 minute onset)
• Post-chemo: 0.5 mL sublingual every 6 hours as needed
• Sleep support: 1.0-2.0 mL sublingual before bed (delivers 25-50 mg CBN)

Evidence context: Delta-8 THC antiemetic evidence [9], delta-9 THC nausea evidence [1][13], CBD anxiolytic buffering [3]

Chronic Pain (Farm Work, Arthritis, Neuropathy)

Typical Lawrence County scenario: Years of working the fields, lifting, bending, operating machinery have left you with chronic back pain, knee pain, or arthritis. Opioids aren’t an option — too risky, too many people in Lawrence County have been hurt by them.

Our recommendation:

• Daytime: 0.3-0.5 mL raw sublingual — provides anti-inflammatory cannabinoid exposure without impairment so you can keep working
• Nighttime: 0.5-1.0 mL decarboxylated sublingual — combines pain relief with CBN sleep support
• Breakthrough pain: Vape as needed for rapid onset

Evidence context: CBD pain evidence [4], delta-9 THC pain evidence [13], beta-caryophyllene CB2 agonism [24], THCa COX-2 inhibition [12]

Sleep Support

Typical Lawrence County scenario: Stress from work, pain from physical labor, or anxiety keeps you up. You’ve tried over-the-counter sleep aids; they leave you groggy.

Our recommendation:

• Before bed: 1.0-2.0 mL sublingual
• At 2.0 mL, this delivers 50 mg CBN — the dosage investigated in 2024 sleep literature
• At 1.0 mL, this delivers 25 mg CBN — above the 20 mg threshold associated with reduced sleep disturbance

Evidence context: CBN sleep evidence [16][17], cannabis and sleep review literature

Anxiety and Stress

Typical Lawrence County scenario: Financial stress, family pressures, PTSD from military service, or the anxiety of managing a chronic condition.

Our recommendation:

• Daytime functional relief: 0.3 mL raw sublingual — CBD and CBG address anxiety pathways without impairment
• Nighttime: 1.0 mL sublingual — full cannabinoid profile with CBN for sleep architecture

Evidence context: CBD anxiety evidence [3], CBG pharmacology [7][8], limonene entourage-effect evidence [20]

General titration principle for all Lawrence County users: Start low, go slow. Begin with 0.25-0.5 mL sublingual and assess effects over 2-3 hours before increasing. Individual responses vary based on body weight, metabolism, tolerance, concurrent medications, and other factors common in our community.

Delivery to Lawrence County: How to Get Our Products

We know transportation is a challenge in rural Alabama. That’s why we’ve made getting our products as simple as possible.

Shipping to Lawrence County

• Nationwide shipping via USPS Priority Mail (2-3 business days), FedEx, or UPS Ground (3-5 business days)
• Discreet packaging with no cannabis branding visible — your neighbors won’t know what’s in the box
• Tracking provided for all orders
• Temperature-stable packaging for Alabama summers
• Signature-required option available for security

Your address in Lawrence County? We’ll ship to:

• Moulton (35650)
• Courtland (35618)
• Town Creek (35672)
• Hillsboro (35643)
• Any rural route or PO Box in Lawrence County

Delivery Times to Alabama

From our Houston facility to Lawrence County typically takes:

• USPS Priority: 2-3 business days
• FedEx/UPS Ground: 3-5 business days

Order by 2 PM Central Time and we’ll ship same day.

International Shipping

For Lawrence County residents with family overseas who need access, we ship internationally with full documentation, COAs, and customs paperwork. Customer accepts all customs and legal responsibility.

The Science Behind Our Formula: GENERAL KNOWLEDGE

This section explains what the research actually says about each component in our formula. We believe you deserve the full truth, not marketing hype.

Research Method and Evidence Weighting

We prioritize sources in this order: human clinical evidence → systematic reviews → NIH/institutional summaries → preclinical literature. This matters because the evidence base is uneven. CBD and delta-9 THC have the strongest human data; other compounds rely more on reviews and animal studies [1]-[29].

Institutional Baseline from NIH and Related Sources

• NCCIH states strongest cannabinoid evidence is for rare epilepsies, chemo-related nausea, and HIV/AIDS appetite/weight loss. Only modest evidence for chronic pain and MS symptoms [1].
• FDA has not approved the cannabis plant itself for medical use [1].
• Safety concerns: impairment, motor vehicle crash risk, cannabis use disorder, pregnancy concerns, contamination, labeling inaccuracy, THC-vape lung injury [1].
• NCCIH warns over-the-counter CBD products may differ from labels and can cause decreased alertness, GI effects, liver injury, drug interactions [1].

Cannabinoid Profiles

CBD (4,500 mg in our formula)

Evidence: Strongest human evidence in our formula, especially as purified product [1]-[6].

• Best supported: Seizure disorders (Epidiolex FDA-approved) [1][2].
• Anxiety: 2024 meta-analysis of 316 participants showed significant anxiolytic signal but authors stress limited clinical sample [3].
• Pain: 2024 review found promising but heterogeneous evidence; trial quality limits confidence [4].
• Sleep: 2023 review found methodologically weak literature with few objective assessments [5].
• Safety: 2023 meta-analysis found liver enzyme elevation and possible drug-induced liver injury, especially concerning for concentrated oral products and polypharmacy [6]. Also diarrhea, sleepiness, appetite changes, mood effects, drug interactions [1].
  Bottom line: Most evidence-developed nonintoxicating cannabinoid, but strong evidence concentrated in specific indications, not broad wellness claims [1]-[6].

CBG (3,000 mg in our formula)

Evidence: Mostly review-level and preclinical; sparse human data [7][8].

• Pharmacology: Biosynthetic precursor with distinct activity vs. THC/CBD. Interacts with cannabinoid receptors, alpha-2 adrenoceptors, 5-HT1A signaling [7].
• Research areas: Neurologic disorders, inflammatory bowel disease, antibacterial activity — mostly preclinical hypotheses [7][8].
• Caution: Being sold commercially while evidence base remains thin [7].
  Bottom line: Promising minor cannabinoid with limited clinical validation, not proven therapeutic [7][8].

Delta-8 THC (6,000 mg in our formula)

Evidence: Pharmacologically relevant, psychoactive, much less clinically characterized than delta-9 [9]-[11].

• Pharmacology: Partial CB1 agonist with cannabimimetic activity; less potent than delta-9, likely due to weaker CB1 affinity [9].
• Public health: 2023 scoping review found evidence dominated by animal studies, product chemistry, use reports, public health concerns. Noted adverse consequences and regulatory/product-quality concerns [10].
• Manufacturing: Commercial interest tied to stability and easier synthesis vs. naturally scarce plant levels; product-byproduct and lab-testing questions matter [11].
  Bottom line: Psychoactive THC analogue with real pharmacologic activity, incomplete human safety characterization, more manufacturing-quality uncertainty than consumers realize [9]-[11].

THCa (1,500 mg in our formula)

Evidence: Important chemically/formulation-wise, low direct human therapeutic evidence [12].

• What it is: Acidic precursor of THC; may represent large share of THC-related content in raw plant material.
• Decarboxylation: Converts to THC during heating; can also change during storage/processing [12].
• Psychoactivity: THCa itself not psychoactive, but only if it stays acidic and isn’t decarboxylated [12].
• Research: In vitro/rodent literature suggests anti-inflammatory, immunomodulatory, neuroprotective, antineoplastic possibilities, but not established human outcomes [12].
  Bottom line: Highly relevant precursor molecule whose interpretation depends on route, temperature, processing, storage. Any claim must account for possible conversion to THC [12].

Delta-9 THC (90 mg in our formula)

Evidence: Strongest human evidence of psychoactive cannabinoids, but clearest adverse-effect burden [1][13]-[15].

• Institutionally supported: Chemo-related nausea/vomiting, HIV/AIDS appetite/weight loss, some MS/pain outcomes [1].
• Pain: 2022 systematic review found high-THC or balanced THC:CBD products may provide short-term pain benefit but increase dizziness, sedation, nausea, discontinuation [13].
• Pharmacokinetics: Inhaled THC: seconds to minutes onset, peaks 15-30 minutes, lasts few hours. Oral THC: later onset, later peak, longer duration [14].
• Mental health risk: 2025 systematic review of high-concentration THC found consistent unfavorable associations with psychosis/schizophrenia outcomes and cannabis use disorder, plus anxiety/depression signals in nontherapeutic settings [15].
• Broader safety: Anxiety/panic at high doses, tachycardia, blood pressure changes, dependency, withdrawal, pregnancy concerns, accidental pediatric exposure, vape-related lung injury [1][14][15].
  Bottom line: Legitimate therapeutic relevance in some settings, but carries clearest intoxication, psychiatric, and dose-related safety liabilities [1][13]-[15].

CBN (750 mg in our formula)

Evidence: Weak human evidence; marketing ahead of data [12][16][17].

• Marketing: Sleep and sedation reputation widespread, but clinical support far thinner than market suggests [16][17].
• Sleep claim: 2021 narrative review screened 99 human-study abstracts, reviewed 8 full-text articles, found no clinical trials using validated sleep questionnaires or polysomnography to substantiate strong sleep-promoting claims [16].
• Broader sleep literature: 2024 review concluded cannabinoid sleep research still doesn’t match real-world use scale; need for better-designed, adequately powered trials remains substantial [17].
• Chemical context: THC can degrade toward CBN under certain conditions, explaining why CBN is discussed in aging/oxidized cannabis contexts [12].
  Bottom line: Cultural reputation stronger than current clinical evidence base — clearest example where marketing outpaces science [16][17].

CBC (750 mg in our formula)

Evidence: Emerging, intriguing, overwhelmingly preclinical or review-based [18][19].

• Pharmacology: 2024 focused review describes distinct pharmacodynamics, pharmacokinetics, receptor behavior vs. better-known cannabinoids. Highlights antinociceptive, antibacterial, anti-seizure as especially interesting [18].
• Older literature: Anti-inflammatory effects, reduced gut hypermobility, modest rodent analgesia, possible neurobiological/antiproliferative relevance — not strong patient-facing evidence [19].
• Safety caveat: Over-the-counter CBC products being sold despite little evidence establishing clinical efficacy or safety [18].
  Bottom line: Scientifically credible minor cannabinoid deserving more research, not already-validated clinical active [18][19].

Terpene Profiles

Terpene claims need even stricter interpretation than cannabinoid claims. Most literature comes from isolated compounds, essential oils, non-cannabis plants, or preclinical models. Robust proof of clinically meaningful entourage effects in humans remains limited [20][29]. For Lawrence County residents familiar with essential oils, aromatherapy, or herbal medicine, these connections make terpene science accessible while keeping claims conservative.

Limonene (Citrus-bright)

Evidence: Largely review and preclinical [20]-[22].

• Potential: 2021 review describes antioxidant, anti-inflammatory, cardioprotective, gastroprotective, immune-modulatory activities — mostly from nonhuman/non-cannabis literature [21].
• Safety: Limonene oxidation products (hydroperoxides) are clinically relevant contact allergens important in patch-testing [22].
  Bottom line: Biologically active, widely discussed, but cannabis-specific therapeutic claims should stay conservative [20]-[22].

Myrcene

Evidence: Mostly preclinical, very limited human evidence [20][23].

• Research: 2021 review describes anxiolytic, antioxidant, anti-inflammatory, analgesic properties, possible mechanisms, but explicitly states human studies lacking [23].
• Interpretation caution: Often invoked as proven sedative explaining “couch-lock,” but claim stronger than human evidence supports [20][23].
  Bottom line: Plausible bioactive terpene, but compound-specific clinical claims remain far ahead of definitive proof [23].

Caryophyllene (Pepper/spice)

Evidence: Among most mechanistically interesting due to direct cannabinoid-system relevance, but still mostly preclinical [24].

• Why it stands out: 2021 focused review describes beta-caryophyllene as selective CB2 receptor agonist — unusual and especially relevant pharmacologically [24].
• Research themes: Anti-inflammatory, immunomodulatory, antioxidant, neuroprotective, gastroprotective discussed, but human confirmation limited [24].
  Bottom line: Strongest candidate for terpene with cannabinoid-system significance, but shouldn’t be described as clinically proven [24].

Pinene (Forest-fresh)

Evidence: Promising preclinical literature, weak human confirmation [20][25].

• Brain health: 2021 review on pinene and linalool found antioxidant, anti-inflammatory, neuroprotective signals justifying future study, but emphasized lack of well-designed clinical trials [25].
• Interpretation caution: Claims that pinene reliably improves memory, sharpens attention, or counterbalances THC cognitive effects remain interesting hypotheses, not settled facts [20][25].
  Bottom line: Deserves scientific attention, but strong cognition-related claims should be presented as exploratory [25].

Linalool (Floral, lavender)

Evidence: Substantial preclinical interest, limited direct clinical confirmation [20][22][25][26].

• Research: Repeatedly discussed regarding stress, mood, brain-health pharmacology. 2021 brain-health review found enough preclinical signal to justify continued investigation while emphasizing lack of robust human trials [25].
• Additional literature: Separate reviews discuss antidepressant mechanisms and neuropharmacologic relevance, but remain translational rather than definitive clinical story [26].
• Safety: Oxidized linalool hydroperoxides recognized allergens in dermatitis literature [22].
  Bottom line: Scientifically credible bioactive terpene, but current evidence supports cautious phrasing rather than firm therapeutic promises [22][25][26].

Humulene (Earthy, woody)

Evidence: Translationally interesting, still early [20][27].

• Scoping review: 2024 review analyzed 340 articles, found broad preclinical evidence for anti-inflammatory and other biologic effects, some rodent work suggesting cannabimimetic properties via CB1 and adenosine A2a pathways [27].
• Interpretation caution: Findings valuable for hypothesis generation but don’t establish consistent human efficacy across pain, inflammation, or mood outcomes [27].
  Bottom line: One of more interesting terpene research targets, but far from clinically settled [27].

Terpinolene (Piney, fruity, sparkling)

Evidence: One of least clinically characterized terpenes in this file [20][28].

• Systematic review: 2021 review screened 2,449 records, included 57 studies, concluded terpinolene has range of reported biological effects but evidence base dominated by in silico, in vitro, and animal studies [28].
• Interpretation caution: Even recent cannabis entourage reviews frame terpene benefits as exploratory, not established compound-specific clinical effects [20].
  Bottom line: Biologically interesting, but especially underdeveloped clinically [20][28].

Research Limits and Interpretation

• Evidence base is highly uneven. CBD and delta-9 THC support most detailed human-facing statements; others require more caution [1]-[29].
• Whole-cannabis extract data, purified-molecule data, semisynthetic cannabinoid data, and terpene-only data are not interchangeable. Common error is letting evidence from one category stand in for another.
• Minor cannabinoids and terpenes are commercially interesting because they’re underexplored, but that also means claims around them often become inflated.
• Product quality matters as much as molecule identity. Labeling inaccuracies, contamination, synthesis byproducts, dose variability, and route-dependent pharmacokinetics all materially affect interpretation in real-world products [1][10][11][14].
• For THCa, chemistry is destiny: storage and heating can change actual exposure profile by converting acidic cannabinoids into neutral cannabinoids like THC [12].

Common Overstatements to Avoid (And What to Say Instead)

• Overstatement: CBN is a clinically proven sleep cannabinoid.
  More accurate: The specific sleep evidence for CBN remains weak and dated, with no strong validated-trial base yet identified [16][17].
• Overstatement: Myrcene is a proven human sedative that reliably explains couch-lock.
  More accurate: Myrcene has plausible preclinical bioactivity, but direct human proof for that common claim is limited [20][23].
• Overstatement: Terpenes have proven entourage effects in patients.
  More accurate: Entourage hypotheses are influential and worth studying, but robust clinical proof remains limited and highly compound-specific [20][29].
• Overstatement: THCa is always nonpsychoactive.
  More accurate: THCa itself is not THC, but heating and processing can convert THCa into THC, changing effective exposure [12].
• Overstatement: Delta-8 THC is safe because it’s hemp-derived.
  More accurate: Delta-8 THC is psychoactive, pharmacologically close to delta-9 THC, and often entangled with manufacturing and testing concerns [9]-[11].

Practical Takeaways for Our Formulas

• Most evidence-developed actives: CBD and delta-9 THC.
• Delta-8 THC is not trivial or purely mild; it’s a psychoactive cannabinoid with less robust safety/efficacy characterization than delta-9 THC.
• THCa meaningfully changes with processing and should not be interpreted the same way in raw, gently handled, and heated formats.
• CBG, CBN, and CBC are scientifically credible but clinically immature compared with CBD/THC.
• The listed terpenes are likely highly relevant to aroma, flavor, and potentially some biologic activity, but compound-specific human therapeutic claims should be made carefully and only where directly supported.

The Formulas: Complete Transparency

RSO Sublingual Oil Formula

Cannabinoid	Amount
CBD	4,500 mg
CBG	3,000 mg
Delta-8 THC	6,000 mg
THCa	1,500 mg
Delta-9 THC	90 mg
CBN	750 mg
CBC	750 mg
Total Cannabinoids	16,590 mg

• Live Terpenes: 5% (limonene, myrcene, caryophyllene, pinene, linalool, humulene, terpinolene)
• Carrier: Organic MCT oil
• Bottle Size: 30 mL (1 fl oz)
• Concentration: 553 mg/mL
• Price: $129.99

RSO Vape Cartridge Formula

Cannabinoid	Percentage
CBD	30%
CBG	20%
Delta-8 THC	15%
THCa	10%
CBN	10%
CBC	10%

• Live Terpenes: 5%+
• Size: 1 gram
• Compatibility: 510-thread (universal battery)
• Price: $49.99

Terpene Profile (Both Products)

• Limonene: Citrus-bright, mood-enhancing
• Myrcene: Relaxing, earthy
• Caryophyllene: Pepper/spice, CB2 activation for inflammation
• Pinene: Forest-fresh, mental clarity
• Linalool: Floral/lavender, calming
• Humulene: Earthy/woody, anti-inflammatory
• Terpinolene: Piney/fruity, complex effects

How to Order in Lawrence County

Online: Visit OilWellCBD.com — our complete RSO guide with science, competitive analysis, protocols, and secure ordering.

Phone: (832) 416-2816 — call us directly. We’re here Monday-Thursday 10 AM-7 PM, Friday-Saturday 10 AM-10 PM, Sunday 10 AM-4 PM Central Time.

Email: [email protected]

Shipping: We’ll ship to any address in Lawrence County — whether you’re in Moulton, Courtland, Town Creek, or on a rural route. Discreet packaging, full tracking, temperature-stable for Alabama heat.

Instagram: @oilwellcbd — follow for educational content, customer stories, and product updates.

Final Words for Lawrence County

We wrote this guide because we believe people in Lawrence County deserve the same level of honest, science-backed cannabis education as people in Houston, Los Angeles, or New York. You shouldn’t have to settle for hype or mystery when you’re making decisions about your health or your family’s health.

Whether you’re a cancer patient at Huntsville Hospital looking for complementary support, a veteran in Hillsboro dealing with PTSD and chronic pain, a farmer in Town Creek with arthritis from decades of physical labor, or a caregiver in Moulton searching for options when the doctors say they’ve done all they can — we see you. We respect you. And we’re committed to giving you the best possible information so you can make the best possible decision.

OilWell Cannabis is more than a brand. It’s a promise to deliver the best, most thoughtful cannabis products available. We’re not here to follow trends. We’re here to set them. And as we continue to grow, our focus remains on maintaining the same integrity, creativity, and commitment that defined us from the day Bentley got up, walked across the room, and brought his ball to play.

Legal Disclaimer: These statements have not been evaluated by the Food and Drug Administration. These products are not intended to diagnose, treat, cure, or prevent any disease. Always consult a qualified healthcare provider before use. Do not operate vehicles or machinery under the influence of psychoactive cannabinoids. Must be 21+ to purchase. Buyer responsible for verifying local laws. Product contains less than 0.3% delta-9 THC by dry weight. THCa converts to delta-9 THC when heated. Use responsibly. Keep out of reach of children. Individual results may vary.

For Lawrence County specifically: Alabama state law permits hemp-derived products with less than 0.3% delta-9 THC. Our products comply with this standard. However, laws evolve. We encourage you to verify current regulations with local authorities. We ship with full documentation and COAs to demonstrate compliance.

OilWell Cannabis
810 Richmond Avenue, Houston, TX 77006
(832) 416-2816 | [email protected]
OilWellCBD.com